XML 112 R58.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 28, 2024
Share-Based Payment Arrangement [Abstract] |
Number and Weighted Average Exercise Price of Options Issued and Outstanding under All Stock Option Plans | The number and weighted-average exercise price of options issued and outstanding under all of the Company’s equity plans are as follows:
| Year Ended December 28, 2024 |  | Year Ended December 30, 2023 |  | Year Ended December 31, 2022
(in millions, except for weighted-average exercise prices) | Shares |  | Weighted-Average Exercise Price |  | Shares |  | Weighted-Average Exercise Price |  | Shares |  | Weighted-Average Exercise Price
Options outstanding, beginning of period | 2.7 |  |  | $ | 87.79 |  |  | 2.8 |  |  | $ | 83.85 |  |  | 2.9 |  |  | $ | 81.38 |
Granted | 0.1 |  |  | 126.49 |  |  | 0.1 |  |  | 177.29 |  |  | 0.1 |  |  | 150.91 |
Canceled | (0.6) |  |  | 82.38 |  |  | — |  |  | 45.96 |  |  | (0.1) |  |  | 162.77 |
Exercised | (0.6) |  |  | 39.47 |  |  | (0.2) |  |  | 43.22 |  |  | (0.1) |  |  | 54.53 |
Options outstanding, end of period | 1.6 |  |  | $ | 110.70 |  |  | 2.7 |  |  | $ | 87.79 |  |  | 2.8 |  |  | $ | 83.85 |
Options exercisable, end of period | 1.5 |  |  | $ | 105.02 |  |  | 2.4 |  |  | $ | 73.79 |  |  | 2.4 |  |  | $ | 65.83 |
Number and Weighted Average Exercise Price of Outstanding and Exercisable Options | The number and weighted-average exercise price of outstanding and exercisable stock options segregated by exercise price ranges were as follows:
| Year Ended December 28, 2024 |  | Year Ended December 30, 2023
(in millions, except range of exercise prices and average remaining contractual life) | Options Outstanding |  | Options Exercisable |  | Options Outstanding |  | Options Exercisable
Range of Exercise Prices | Number of Options |  | Average Remaining Contractual Life |  | Number of Options |  | Number of Options |  | Average Remaining Contractual Life |  | Number of Options
$15.00 to $50.00 | 0.3 |  |  | 1.0 |  | 0.3 |  |  | 1.2 |  |  | 1.5 |  | 1.2 |
$50.01 to $80.00 | — |  |  | 1.7 |  | — |  |  | — |  |  | 2.5 |  | — |
$80.01 to $120.00 | 0.6 |  |  | 2.0 |  | 0.6 |  |  | 0.7 |  |  | 3.7 |  | 0.7 |
$120.01 to $160.00 | 0.4 |  |  | 4.3 |  | 0.3 |  |  | 0.4 |  |  | 6.0 |  | 0.3 |
$160.01 to $200.00 | 0.2 |  |  | 4.3 |  | 0.2 |  |  | 0.3 |  |  | 7.0 |  | 0.1 |
$200.01 to $230.00 | — |  |  | 5.2 |  | — |  |  | — |  |  | 6.5 |  | — |
$230.01 to $280.00 | 0.1 |  |  | 3.9 |  | 0.1 |  |  | 0.1 |  |  | 7.0 |  | 0.1 |
Total | 1.6 |  |  | 3.2 |  | 1.5 |  |  | 2.7 |  |  | 4.9 |  | 2.4 |
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity | The number of RSUs issued and outstanding under all of the Company’s equity plans are as follows:
| Year Ended December 28, 2024 |  | Year Ended December 30, 2023 |  | Year Ended December 31, 2022
(in millions, except for weighted-average grant date fair value) | Units |  | Weighted-Average Grant Date Fair Value |  | Units |  | Weighted-Average Grant Date Fair Value |  | Units |  | Weighted-Average Grant Date Fair Value
RSUs outstanding, beginning of period | 3.5 |  |  | $ | 105.87 |  |  | 3.2 |  |  | $ | 105.65 |  |  | 3.0 |  |  | $ | 104.13 |
Granted | 0.3 |  |  | 129.81 |  |  | 0.5 |  |  | 125.44 |  |  | 0.3 |  |  | 148.52 |
Canceled | (2.8) |  |  | 96.65 |  |  | (0.1) |  |  | 172.19 |  |  | (0.1) |  |  | 168.90 |
Vested | (0.2) |  |  | 146.85 |  |  | (0.1) |  |  | 173.18 |  |  | — |  |  | 184.04 |
RSUs outstanding, end of period | 0.8 |  |  | $ | 135.88 |  |  | 3.5 |  |  | $ | 105.87 |  |  | 3.2 |  |  | $ | 105.65 |
Schedule of Nonvested Performance-based Units Activity | The number of PSUs outstanding under all of the Company’s equity plans are as follows:
| Year Ended December 28, 2024 |  | Year Ended December 30, 2023 |  | Year Ended December 31, 2022
(in millions, except for weighted-average grant date fair value) | Units |  | Weighted-Average Grant Date Fair Value |  | Units |  | Weighted-Average Grant Date Fair Value |  | Units |  | Weighted-Average Grant Date Fair Value
PSUs outstanding, beginning of period | 0.3 |  |  | $ | 190.04 |  |  | 0.3 |  |  | $ | 180.04 |  |  | 0.3 |  |  | $ | 168.68 |
Granted(1) | 0.2 |  | (1) | 164.19 |  |  | 0.1 |  | (2) | 204.67 |  |  | 0.3 |  | (3) | 145.49 |
Canceled | (0.2) |  |  | 185.37 |  |  | — |  |  | 155.98 |  |  | (0.1) |  |  | 139.70 |
Vested | (0.1) |  |  | 73.00 |  |  | (0.1) |  |  | 179.42 |  |  | (0.2) |  |  | 127.46 |
PSUs outstanding, end of period | 0.2 |  |  | $ | 169.99 |  |  | 0.3 |  |  | $ | 190.04 |  |  | 0.3 |  |  | $ | 180.04 |
(1) On February 26, 2024, the Audit Committee approved the weighted payout percentage for the 2021 PSU awards (three-year performance period), which were based upon the Company’s actual fiscal year 2023 performance against pre-established performance objectives. Included in the granted amount are those additional PSUs earned based on actual performance achieved. These PSUs were originally awarded at target. (2) On February 27, 2023, the Audit Committee approved the weighted payout percentage for the 2020 PSU awards (three-year performance period), which were based upon the Company’s actual fiscal year 2022 performance against pre-established performance objectives. Included in the granted amount are those additional PSUs earned based on actual performance achieved. These PSUs were originally awarded at target. (3) On February 14, 2022, the Audit Committee approved the weighted payout percentage for the 2019 PSU awards (three-year performance period), which were based upon the Company’s actual fiscal year 2021 performance against pre-established performance objectives. Included in the granted amount are those additional PSUs earned based on actual performance achieved. These PSUs were originally awarded at target.
Range of Assumptions Used and Resulting Weighted-Average Fair Value of Options Granted at Date of Grant | The range of assumptions used and the resulting weighted-average fair value of options granted at the date of grant were as follows:
| Year Ended December 28, 2024 |  | Year Ended December 30, 2023 |  | Year Ended December 31, 2022
Risk-free interest rate | 3.3% to 4.2% |  | 3.6% to 4.2% |  | 1.0% to 1.9%
Expected term (in years) | 4.6 years to 5.9 years |  | 5.1 years to 5.9 years |  | 5.1 years to 5.7 years
Estimated volatility | 33.3% to 42.6% |  | 31.6% to 36.7% |  | 31.2% to 38.9%
Expected dividends | 0% |  | 0% |  | 0%
Weighted-average fair value of options granted | $59.60 per share |  | $75.08 per share |  | $46.69 per share
Share-Based Compensation Expense Included in Consolidated Statements of Operations | The following table presents the total stock-based compensation expense that is included in each functional line item of the consolidated statements of operations:
(in millions) | Year Ended December 28, 2024 |  | Year Ended December 30, 2023 |  | Year Ended December 31, 2022
Cost of goods sold | $ | 1.0 |  |  | $ | 1.1 |  |  | $ | 1.0 |
Selling, general and administrative | 25.2 |  |  | (1.5) |  |  | 32.9 |
Research and development | 15.3 |  |  | 7.4 |  |  | 13.8 |
Total | $ | 41.5 |  |  | $ | 7.0 |  |  | $ | 47.7 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested performance-based units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration